GOLDMAN SACHS GROUP INC - PREVAIL THERAPEUTICS INC ownership

PREVAIL THERAPEUTICS INC's ticker is PRVL and the CUSIP is 74140Y101. A total of 77 filers reported holding PREVAIL THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of PREVAIL THERAPEUTICS INC
ValueSharesWeighting
Q4 2020$6,771,000
+1077.6%
293,489
+420.0%
0.00%
Q3 2020$575,000
+19.3%
56,444
+74.3%
0.00%
Q2 2020$482,000
+91.3%
32,377
+56.7%
0.00%
Q1 2020$252,000
+2.0%
20,665
+32.6%
0.00%
Q4 2019$247,000
-50.3%
15,579
-58.6%
0.00%
Q2 2019$497,00037,6420.00%
Other shareholders

There were no reported owners of PREVAIL THERAPEUTICS INC in Q3 2020.

NameSharesValueWeighting ↓
View complete list of PREVAIL THERAPEUTICS INC shareholders